Publication | Open Access

Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial

Gastrointestinal OncologyMedicineRandomized Bebyp TrialColorectal CancerPathologyMetastatic Colorectal CancerCancer TreatmentOncologyRadiation OncologyFinal Results